BERGER DAVID B, EVP, GEN. COUNSEL & SECRETARY, sold 10,000 shares of the Tandem Diabetes Care, Inc. (NASDAQ:TNDM) in an exchange that happened on January 8th. The stock was sold at an average price of $40.08 per share, amounting to a transaction worth $400,751. The sale was made public in a document filed with the SEC. Additionally, EVP, CHIEF OPERATING OFFICER Sheridan John F sold 20,000 shares of this stock in a transaction that took place on January 2nd. The stock was sold at an average price of $35.68 per share, for a total exchange amounting to $713,511. After the transaction, the EVP, CHIEF OPERATING OFFICER Sheridan John F currently holds 666 shares of the company’s stock, which is worth approximately $28105.
With this stock price’s latest movement, it is now -19.70% away from its 1-year high and 1871.96% higher than its 1-year low price. In the past seven days, the stock price volatility for Tandem Diabetes Care, Inc. was 8.18%, whereas its volatility in the past 30 days has been 8.02%. This public company’s stock also has a beta score of 0.43. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) most recently published its quarterly earnings results. The publicly-traded organization reported revenue of $46.26 million for the quarter, compared to the average analyst forecast calling for $41.83 million, which was surpassing the analyst consensus estimate.
Shares of Tandem Diabetes Care, Inc. (TNDM) surged 3.84%, amounting to a gain of $1.56 per share, to finish the regular trading session at $42.20 on Thursday 01/10/2019. After beginning the session at $39.92, shares of Tandem Diabetes Care, Inc. reached as high as $43.98 during the day, while hitting a 1-day low of $39.68. Trade volume reached 2,845,378 shares against this stock’s average daily volume of 1.74M shares, with a total float of 51.30M. As a consequence of the price increase, Tandem Diabetes Care, Inc. now has a current market value of 2.37B.
OPKO Health, Inc. (NASDAQ:OPK) added 2.74% to its trading price by the close of the most recent session, jumping from its previous closing price of $3.65 to $3.75. This stock increased in value by 14.33% during the last 7-day period, and experienced a gain of 12.95% over the past 30-day period. In the past three months, this stock’s price grew by 8.07% , and subtracted -22.36% to its price during the last six months of trading. OPK demonstrated a yearly price loss of -26.76% , while its year-to-date (YTD) price performance has been up 24.58% . This stock’s price changed by +60.60% compared to its 90-day low, and moved down -4.34% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the OPK stock as “Buy”. In the short-term, OPKO Health, Inc. (OPK) has a 20-day average volume of 6,561,175 shares and short-term indicators sets the OPK stock as “ 40% Buy ” on average basis. In the medium-term, OPK stock has a 50-Day average volume of 5,158,320 shares and medium-term indicators gave the average rating of “ 25% Buy ”, while in the long-term period the FB stock has a 100-Day average volume of 5,254,528 shares. On average, long-term indicators rated the stock as “67% Sell ”. The overall picture from all short, medium and long-term indicators sets the OPK stock as “16% Buy ” on average basis.
Recently, multiple brokerages have sent out reports on OPK. JP Morgan, for example, Downgrade its rating on shares of OPKO Health, Inc. from “Neutral ” to a “ Underweight”according to a research note from Friday March 2nd, 2018. while giving the stock a “ Neutral” from “Overweight ” rating, as stated in a research report from Thursday, September 14th, 2017. Standpoint Research, on the other hand, Reiterated a “Buy” rating on this stock, while posting a $18 price target on shares of this company’s stock in a research note dated Tuesday, June 21st, 2016.
In other news related to OPKO Health, Inc. stock, 27.50% shares of OPK held by institutions. The total number of institutions who held the OPK shares was 270, according to most recent SEC filling. During the past quarter, total 153,965,385 shares held by institutions with the net change of 9,565,591 shares. In the meantime, 29 new institutions bought the shares of OPKO Health, Inc. for the first time and 42 institutions sold all their holdings in the company’s common stock. 97 institutions increased their investment in the OPK stock and 111 institutions decreased their investment in the OPKO Health, Inc. (OPK)’s stock during the last quarter.